Condition
CREST Syndrome
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 2 (1)
Trial Status
Terminated1
Unknown1
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT02374320Phase 2TerminatedPrimary
Exparel as a Nerve Block for Severe Hand Pain
NCT04656704Early Phase 1Withdrawn
Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease
NCT03972566UnknownPrimary
Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon
Showing all 3 trials